The global regenerative medicine market is expected to grow at a CAGR of 6.24% to reach a total market size of US$59.482 billion by 2024, increasing from US$41.364 billion in 2018. Regenerative drugs or medicines are used to heal body tissues or organs from within. The process is called rejuvenation in which these medicines repair the damaged body organs which otherwise cannot heal naturally.
Regenerative medicines also help in replacement where healthy cells, tissues, or organs are used from a dead or healthy donor to replace damaged cells, tissues, or organs. The other way to heal damaged tissue with these medicines is by delivering healthy cells or tissues to diseased or damaged cells in order to retain the body’s normal functioning which is known as regeneration.
Rising government investments in regenerative medicine research are considered key drivers for the growth of the market during the forecast period. In addition, an increasing number of product approvals coupled with a growing pipeline of regenerative medicine products will further propel the market growth opportunities in the coming years.
The Regenerative Medicine Market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key markets, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, End User, and geography.
Based on type, the market has been segmented as Stem cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecules & Biologics. On the basis of application, the global regenerative drug market is segmented as cardiovascular, oncology, dermatology, musculoskeletal, and others. End-users of the global regenerative drugs market include hospitals, biomedical laboratories, and research centers.
Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the regenerative medicine market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the regenerative medicine market.
Frequently Asked Questions (FAQs)